UCB is a Belgian manufacturer of biopharmaceutical products. The company is engaged in the provision of therapy for central nervous system disorders, inflammatory and oncology disorders. UCB head office is located in Brussels.
| Registrars: |
| Address: | |
| Phone: | |
| Fax: | |
| Website: | |
| Email: |
| ISIN: | BE0003739530 |
| Main Indices: | Cmc Markets, BEL 20, CMC Markets Plc |